Search Results - "Re, Vincent Lo"

Refine Results
  1. 1

    The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis by Yehia, Baligh R, Schranz, Asher J, Umscheid, Craig A, Lo Re, 3rd, Vincent

    Published in PloS one (02-07-2014)
    “…Identifying gaps in care for people with chronic hepatitis C virus (HCV) infection is important to clinicians, public health officials, and federal agencies…”
    Get full text
    Journal Article
  2. 2

    Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study by Butt, Adeel Ajwad, Yan, Peng, Shaikh, Obaid S., Lo Re, Vincent, Abou-Samra, Abdul-Badi, Sherman, Kenneth E.

    Published in Journal of hepatology (01-08-2020)
    “…Treating HCV infection reduces overall mortality and reduces the risk of multiple extrahepatic complications. Whether the reduction in mortality is primarily…”
    Get full text
    Journal Article
  3. 3

    Impact of hepatitis C virus treatment on the risk of non‐hepatic cancers among hepatitis C virus‐infected patients in the US by Wang, Wei, Lo Re, Vincent, Guo, Yi, Xiao, Hong, Brown, Joshua, Park, Haesuk

    Published in Alimentary pharmacology & therapeutics (01-11-2020)
    “…Summary Background Hepatitis C virus (HCV) infection is associated with with an increased risk of non‐hepatic cancers, but the impact of HCV treatment on…”
    Get full text
    Journal Article
  4. 4

    Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals by Do, Albert, Esserman, Denise A., Krishnan, Supriya, Lim, Joseph K., Taddei, Tamar H., Hauser, Ronald G., Tate, Janet P., Re, Vincent Lo, Justice, Amy C.

    “…Background Cure from chronic hepatitis C virus (HCV) infection is readily achievable with direct-acting antivirals (DAA), but little is known about optimal…”
    Get full text
    Journal Article
  5. 5

    Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases by Weinstein, Erica J., Ritchey, Mary Elizabeth, Lo Re, Vincent

    Published in Pharmacoepidemiology and drug safety (01-01-2023)
    “…Real‐world healthcare data, including administrative and electronic medical record databases, provide a rich source of data for the conduct of…”
    Get full text
    Journal Article
  6. 6

    Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications by Akgün, Kathleen M., Krishnan, Supriya, Tate, Janet, Bryant, Kendall, Pisani, Margaret A., Lo Re, Vincent, Rentsch, Christopher T., Crothers, Kristina, Gordon, Kirsha S., Justice, Amy C.

    “…Background People aging with and without HIV (PWH and PWoH) want to avoid neurocognitive dysfunction, especially delirium. Continued use of alcohol in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Liver fibrosis progression in hepatitis C virus infection after seroconversion by Butt, Adeel A, Yan, Peng, Lo Re, 3rd, Vincent, Rimland, David, Goetz, Matthew B, Leaf, David, Freiberg, Matthew S, Klein, Marina B, Justice, Amy C, Sherman, Kenneth E

    Published in JAMA internal medicine (01-02-2015)
    “…Knowing the rate of liver fibrosis progression in hepatitis C virus (HCV)-infected persons can help inform patients and providers (clinicians, medical…”
    Get more information
    Journal Article
  9. 9

    A SEMIPARAMETRIC MODELING APPROACH USING BAYESIAN ADDITIVE REGRESSION TREES WITH AN APPLICATION TO EVALUATE HETEROGENEOUS TREATMENT EFFECTS by Zeldow, Bret, Re, Vincent Lo, Roy, Jason

    Published in The annals of applied statistics (01-09-2019)
    “…Bayesian Additive Regression Trees (BART) is a flexible machine learning algorithm capable of capturing nonlinearities between an outcome and covariates and…”
    Get full text
    Journal Article
  10. 10

    Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES by Butt, Adeel A., Ren, Yanjie, Re, Vincent Lo, Taddei, Tamar H., Kaplan, David E.

    Published in Clinical infectious diseases (01-07-2017)
    “…Background. Identifying hepatitis C virus (HCV)-positive persons at high risk of early complications can help prioritize treatment decisions. We conducted this…”
    Get full text
    Journal Article
  11. 11

    HCV epidemiology in high-risk groups and the risk of reinfection by Midgard, Håvard, Weir, Amanda, Palmateer, Norah, Lo Re, Vincent, Pineda, Juan A, Macías, Juan, Dalgard, Olav

    Published in Journal of hepatology (01-10-2016)
    “…Summary Injecting risk behaviours among people who inject drugs (PWID) and high-risk sexual practices among men who have sex with men (MSM) are important…”
    Get full text
    Journal Article
  12. 12

    Drug‐Drug Interaction Surveillance Study: Comparing Self‐Controlled Designs in Five Empirical Examples in Real‐World Data by Bykov, Katsiaryna, Li, Hu, Kim, Sangmi, Vine, Seanna M., Lo Re, Vincent, Gagne, Joshua J.

    Published in Clinical pharmacology and therapeutics (01-05-2021)
    “…Self‐controlled designs, specifically the case‐crossover (CCO) and the self‐controlled case series (SCCS), are increasingly utilized to generate real‐world…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection by Saine, M Elle, Moore, Tyler M, Szymczak, Julia E, Bamford, Laura P, Barg, Frances K, Mitra, Nandita, Schnittker, Jason, Holmes, John H, Lo Re, 3rd, Vincent

    Published in PloS one (05-02-2020)
    “…Stigma around hepatitis C virus (HCV) infection is an important and understudied barrier to HCV prevention, treatment, and elimination. To date, no validated…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance by Lo Re, Vincent, Gowda, Charitha, Urick, Paul N, Halladay, Joshua T, Binkley, Amanda, Carbonari, Dena M, Battista, Kathryn, Peleckis, Cassandra, Gilmore, Jody, Roy, Jason A, Doshi, Jalpa A, Reese, Peter P, Reddy, K. Rajender, Kostman, Jay R

    Published in Clinical gastroenterology and hepatology (01-07-2016)
    “…Background & Aims The high costs of direct-acting antiviral (DAA) agents to treat chronic hepatitis C virus (HCV) infection have resulted in denials of…”
    Get full text
    Journal Article